1) Health care and insurance systems in the world: HTA for universal health coverage
2) HTA agencies in the world: Historical perspectives
3) The principles and methods of HTA and pharmacoeconomics (I)
4) The principles and methods of HTA and pharmacoeconomics (II)
5-8) Group presentation for selected countries such as UK-NICE, France-HAS, Gernany-IQWiG, Korea-HIRA/NECA, Thailand-HITAP, Singapore-ACE, and China/Taiwan.
9) HTA policy in Japan: world-premiere ICER-based price adjustment for value-based pricing
10) invited lecture by a US professor: US value framework and CEA Registry in USA
11) invited lecture by an international HTA expert: research consulting for HTA in the world
12) invited lecture by a Canadian professor: CADTH and ISPOR
13) HTA to the future beyond Covid-19 pandemic